Jim Cramer highlighted a market rotation away from tech and data center stocks toward enterprise software and pharmaceuticals, driven by political opposition to data center construction and bond market volatility. Software companies like ServiceNow, Salesforce, and Adobe are benefiting as constrained data center capacity boosts demand for efficiency solutions. Pharmaceuticals, led by Johnson & Johnson and Merck, attract investors for their strong balance sheets and pipelines, with Moderna surging on vaccine data. The market currently favors buybacks over fundamentals, signaling investor preference for financial engineering amid uncertainty about demand and regulatory risks.
ServiceNow's stock surged 29% in August following a strong Q2 earnings report that beat expectations with 24% revenue growth and significant AI product adoption. The company raised its FY26 subscription revenue guidance and set ambitious long-term ta...
Palantir Technologies and BigBear.ai, both serving government AI and data analytics, saw their stocks rise 4% on Friday, with Palantir surpassing the $180 psychological level. This move reflects regained ground after earlier losses in 2026 rather tha...
